| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals Plc (JAZZ) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. JAZZ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.18M | $268.23M | - | |
| Dir | 390.7K | $88.58M | - | |
| CEO | 152.2K | $34.51M | - | |
| VP | 72.6K | $16.47M | - | |
| CFO | 59.6K | $13.51M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2017 | McGill Iain | SVP, Europe &Rest Of World | Sale+OE | 8,000 | $133.42 | $1,067,357.60 | -28.2% | |
| Nov 17, 2017 | Enright Patrick G74 | Director | Sell | 352 | $133.19 | $46,882.88 | -20.5% | |
| Oct 2, 2017 | Cozadd Bruce C59 | Chairman &CEO | Sell | 1,000 | $150.00 | $150,000.00 | -0.4% | |
| Sep 12, 2017 | Cozadd Bruce C59 | Chairman &CEO | Sell | 1,000 | $153.52 | $153,520.00 | -0.4% | |
| Aug 25, 2017 | Enright Patrick G74 | Director | Sell | 351 | $148.40 | $52,088.40 | -17.0% | |
| Aug 15, 2017 | Miller Michael Patrick46 | EVP, Us Commercial | Sell | 200 | $144.38 | $28,876.00 | -0.9% | |
| Aug 14, 2017 | Treacy Paul | SVP, Technical Operations | Sell | 1,304 | $143.32 | $186,884.40 | -3.7% | |
| Aug 11, 2017 | Winningham Rick E64 | Director | Sell | 662 | $142.37 | $94,247.89 | -2.9% | |
| Aug 11, 2017 | Sohn Catherine A.55 | Director | Sell | 662 | $142.37 | $94,247.89 | -4.6% | |
| Aug 11, 2017 | Schnee Elmar | Director | Sell | 1,199 | $142.37 | $170,698.69 | -7.0% |